Skip to content

Inspection Record

Forest/Inwood Laboratories, Inc. — FDA 483 Findings

US FDAInspected 2015-07-24Published 2024-01-17 14 findingsOther quality systemEquipment and facilityMaterial and supplier controlStability and storage

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

Reference standards used by the firm for analysis are accepted and used as 100% pure, although certificates of analysis, in certain instances, do not contain adequate data on the purity or potency of the standard.

2Equipment and facility

The following was noted regarding the multiprobe robotic micro-pipettor, and the automated solid phase extractors: a) There are no written SOPs for the calibration of either the multiprobe robotic micro-pippettor, or the automated solid phase extractor units.

3Other quality system

The stock solutions for Sgiiigemeiidilillke made on 8/22/95, and for ier made on 3/4/96, were each used for the preparation of both QC and standard curve solutions.

4Other quality system

The reported assay precision in the analytical runs was not accurate because the .

5Other quality system

The firm’s acceptance criteria for the injection of the mix solution at the beginning of the analytical run is not adequate to assure reproducibility of the chromatographic system.

6Other quality system

For para-hydroxyrimantadine hydrochloride used in study FLU-PK-03-000, the calculated percentages of axial and equatorial isomers were 47.4 and 52.6 respectively.

7Material and supplier control

Firm's SOPs allow for non-USP analytical reference standards, which are not covered by a supplier's assigned expiration date, to be used for up to giiiiaeenaiiivess without re-testing or other available supporting stability data.

8Other quality system

Reference standards are weighed on an analytical balance and the weights recorded to 4 decimal places (eg.

9Other quality system

Reference standards are used for analysis with an assumed 100% potency regardless of the actual potency/purity.

10Other quality system

There was no established criteria fordetermining assay interference.

11Equipment and facility

Firm's SOPs require calibration of the manually operated digital micro-pipettes

12Stability and storage

Freezer and refrigeration units used to store study specimens and test solutions are not monitored by any continuous time/temperature recording devices.

13Other quality system

Reference standards used for analysis are not dried prior to weighing nor are loss on drying or water factors used to correct the weights.

14Stability and storage

Firm’s SOPs allow for the stability of stock solutions to be checked by chromatographic comparison with the mix solution.

A record as of the US FDA document published on 2024-01-17. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Forest/Inwood Laboratories, Inc. company profile — full historyAll US FDA findings US FDA documents, 2024 Go to Findings search
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.